Increased striatal glutamate transporter by repeated intermittent administration of methamphetamine

Psychiatry and Clinical Neurosciences

Volumn 50, Issue 3, 1996, Pages 161-164

  Shirai, Yutaka ^a   Shirakawa, Osamu ^a   Nishino, Naoki ^a   Saito, Naoaki ^b   Nakai, Hisao ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

behavioral sensitization; GLT 1; glutamic acid; immunoquantification methamphetamine; rat; striatum

Indexed keywords

CARRIER PROTEIN; GLUTAMIC ACID; METHAMPHETAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; HEAD MOVEMENT; IMMUNOREACTIVITY; MALE; NONHUMAN; RAT; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029996908     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.1996.tb01682.x     Document Type: Article

References (23)

1. Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease. Trends Neural. Sci. 1990; 13: 272-276.
2. Deutsch SI, Mastropaolo J, Schwartz BL, Rosse KB, Morihisa JM. A 'glutamate hypothesis' of schizophrenia: Rationale for pharmacotherapy with glycine. Clin. Neuropharmacol. 1989; 12: 1-13.
3. Harrison PJ, McLaughlin D, Kerwin RW. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 1991; 337: 450-452.
4. 3H] kainic acid binding in the prefrontal cortex in schizophrenia. Neurosci. Lett. 1983; 40: 245-250.
5. Ishimaru -M, Kurumaji A, Toru M. Increase in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis. Biol. Psychiatry 1994; 35: 84-95.
6. Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 1986; 11: 157-198.
7. Pines P, Danbolt NC, Bjoras M et al. Cloning and expression of a rat brain L-glutamate transporter. Nature 1992; 360: 464-467.
8. Kanai Y, Hediger MA. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 1992; 360: 467-471.
9. + -dependent glutamate/ aspartate transporter from rat brain. Proc. Natl Acad. Sci. USA 1992; 89: 10 955-10 959.
10. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 1995; 375: 599-603.
11. Rothstein JD, Martin L, Levey AI et al. Localization of neuronal and glial glutamate transporters. Neuron 1994; 13: 713-725.
12. Mennerick S, Zorumski CF. Glial contributions to excitatory neurotransmission in cultured hippocampal cells. Nature 1994; 368: 59-62.
13. Ujike H, Akiyama K, Otsuki S. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psycho-pharmacology 1990; 102: 459-464.
14. +] coupled L-glutamate transporter purified from rat brain is located in glial cell processes. Neuroscience 1992; 51: 295-310.
15. Kerkerian L, Dusticier N, Nieoullon A. Modulatory effects of dopamine on high-affinity glutamate uptake in the rat striatum. J. Neurochem. 1987; 48: 1301-1306.
16. Sonsalla PK, Nicklas WJ, Heikkila RE. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 1989; 243: 398-400.
17. Nash JF, Yamamoto BK. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4- methylenedioxy-methamphetamine. Brain Res. 1992; 581: 237-243.
18. Abekawa T, Ohmori T, Koyama T. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 1994; 643: 279-281.
19. Dahl D, Bignami A. Glial fibrillary acidic protein from normal human brain, purification and properties. Brain Res. 1973; 57: 343-360.
20. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 1991; 258: 882-890.
21. Rothstein JD, Tabakoff B. Glial neuronal glutamate transport following glutamate synthetase inhibition. Biochem. Pharmacol. 1985; 34: 73-79.
22. Karler R, Calder LD, Chaudhry IA, Turkanis SA. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci. 1989; 45: 599-606.
23. Karler R, Calder LD, Thai LH, Bedingfield JB. A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res. 1994; 658: 8-14.